Scott Tomlins
Scott Tomlins
Associate Professor of Pathology and Urology
Adresse e-mail validée de
Citée par
Citée par
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins, DR Rhodes, S Perner, SM Dhanasekaran, R Mehra, XW Sun, ...
science 310 (5748), 644-648, 2005
Integrative clinical genomics of advanced prostate cancer
D Robinson, EM Van Allen, YM Wu, N Schultz, RJ Lonigro, JM Mosquera, ...
Cell 161 (5), 1215-1228, 2015
The mutational landscape of lethal castration-resistant prostate cancer
CS Grasso, YM Wu, DR Robinson, X Cao, SM Dhanasekaran, AP Khan, ...
Nature 487 (7406), 239-243, 2012
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
CG Kleer, Q Cao, S Varambally, R Shen, I Ota, SA Tomlins, D Ghosh, ...
Proceedings of the National Academy of Sciences 100 (20), 11606-11611, 2003
The molecular taxonomy of primary prostate cancer
A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ...
Cell 163 (4), 1011-1025, 2015
Integrative molecular concept modeling of prostate cancer progression
SA Tomlins, R Mehra, DR Rhodes, X Cao, L Wang, SM Dhanasekaran, ...
Nature genetics 39 (1), 41-51, 2007
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
SA Tomlins, B Laxman, SM Dhanasekaran, BE Helgeson, X Cao, ...
Nature 448 (7153), 595-599, 2007
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
DR Robinson, YM Wu, P Vats, F Su, RJ Lonigro, X Cao, ...
Nature genetics 45 (12), 1446, 2013
An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression
J Yu, J Yu, RS Mani, Q Cao, CJ Brenner, X Cao, X Wang, L Wu, J Li, M Hu, ...
Cancer cell 17 (5), 443-454, 2010
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
H Beltran, D Prandi, JM Mosquera, M Benelli, L Puca, J Cyrta, C Marotz, ...
Nature medicine 22 (3), 298-305, 2016
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression
S Varambally, J Yu, B Laxman, DR Rhodes, R Mehra, SA Tomlins, ...
Cancer cell 8 (5), 393-406, 2005
Recurrent gene fusions in prostate cancer
C Kumar-Sinha, SA Tomlins, AM Chinnaiyan
Nature Reviews Cancer 8 (7), 497-511, 2008
Role of the TMPRSS2-ERG gene fusion in prostate cancer
SA Tomlins, B Laxman, S Varambally, X Cao, J Yu, BE Helgeson, Q Cao, ...
Neoplasia 10 (2), 177-IN9, 2008
TMPRSS2: ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer
S Perner, F Demichelis, R Beroukhim, FH Schmidt, JM Mosquera, S Setlur, ...
Cancer research 66 (17), 8337-8341, 2006
Repression of E-cadherin by the polycomb group protein EZH2 in cancer
Q Cao, J Yu, SM Dhanasekaran, JH Kim, RS Mani, SA Tomlins, R Mehra, ...
Oncogene 27 (58), 7274-7284, 2008
Identification of targetable FGFR gene fusions in diverse cancers
YM Wu, F Su, S Kalyana-Sundaram, N Khazanov, B Ateeq, X Cao, ...
Cancer discovery 3 (6), 636-647, 2013
TMPRSS2: ETV4 gene fusions define a third molecular subtype of prostate cancer
SA Tomlins, R Mehra, DR Rhodes, LR Smith, D Roulston, BE Helgeson, ...
Cancer research 66 (7), 3396-3400, 2006
A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer
B Laxman, DS Morris, J Yu, J Siddiqui, J Cao, R Mehra, RJ Lonigro, ...
Cancer research 68 (3), 645-649, 2008
Probabilistic model of the human protein-protein interaction network
DR Rhodes, SA Tomlins, S Varambally, V Mahavisno, T Barrette, ...
Nature biotechnology 23 (8), 951-959, 2005
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma
N Palanisamy, B Ateeq, S Kalyana-Sundaram, D Pflueger, ...
Nature medicine 16 (7), 793-798, 2010
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20